Two Sigma Investments LP Reduces Holdings in Clover Health Investments, Corp. (NASDAQ:CLOV)

Two Sigma Investments LP decreased its position in shares of Clover Health Investments, Corp. (NASDAQ:CLOV - Free Report) by 69.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 504,295 shares of the company's stock after selling 1,134,656 shares during the period. Two Sigma Investments LP owned about 0.10% of Clover Health Investments worth $1,589,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of the business. Triumph Capital Management bought a new position in shares of Clover Health Investments during the fourth quarter worth about $45,000. Parallax Volatility Advisers L.P. boosted its position in shares of Clover Health Investments by 47.7% in the fourth quarter. Parallax Volatility Advisers L.P. now owns 19,855 shares of the company's stock valued at $63,000 after acquiring an additional 6,408 shares during the period. ADAR1 Capital Management LLC acquired a new position in shares of Clover Health Investments during the 4th quarter worth approximately $73,000. Thoroughbred Financial Services LLC bought a new position in Clover Health Investments during the 4th quarter worth $84,000. Finally, Dark Forest Capital Management LP bought a new position in shares of Clover Health Investments in the 4th quarter valued at $102,000. 19.77% of the stock is owned by institutional investors and hedge funds.

Clover Health Investments Trading Down 0.2%

Shares of CLOV stock traded down $0.01 during trading on Friday, reaching $3.02. 2,219,886 shares of the company's stock traded hands, compared to its average volume of 6,659,029. The firm's 50-day moving average is $3.43 and its 200 day moving average is $3.65. The company has a market capitalization of $1.53 billion, a P/E ratio of -15.07 and a beta of 1.99. Clover Health Investments, Corp. has a 1 year low of $0.90 and a 1 year high of $4.87.

Clover Health Investments (NASDAQ:CLOV - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.12. The firm had revenue of $462.33 million for the quarter, compared to analysts' expectations of $466.93 million. Clover Health Investments had a negative return on equity of 25.46% and a negative net margin of 5.92%. As a group, sell-side analysts predict that Clover Health Investments, Corp. will post -0.12 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group boosted their target price on shares of Clover Health Investments from $4.20 to $4.50 and gave the stock a "buy" rating in a report on Monday, March 3rd.

Clover Health Investments Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.